A novel concept of treatment of diffuse or multiple pleural tumors by boron neutron capture therapy (BNCT)

Abstract Two patients, one with malignant pleural mesothelioma and one with a malignant short spindle cell tumor, received boron neutron capture therapy (BNCT). In each case, the tumors regressed or remained stable in size for 3–6 months following BNCT. No acute or late adverse events higher than gr...

Full description

Saved in:
Bibliographic Details
Published inRadiotherapy and oncology Vol. 88; no. 2; pp. 192 - 195
Main Authors Suzuki, Minoru, Endo, Kazuo, Satoh, Hiroaki, Sakurai, Yoshinori, Kumada, Hiroaki, Kimura, Hiroyuki, Masunaga, Shinichiro, Kinashi, Yuko, Nagata, Kenji, Maruhashi, Akira, Ono, Koji
Format Journal Article
LanguageEnglish
Published Ireland Elsevier Ireland Ltd 01.08.2008
Subjects
Adult
Boron Compounds - therapeutic use
Boron neutron capture therapy
Boron Neutron Capture Therapy - methods
Fatal Outcome
Hematology, Oncology and Palliative Medicine
Humans
Male
Malignant pleura mesothelioma
Mesothelioma - radiotherapy
Middle Aged
Pilot Projects
Pleural Neoplasms - radiotherapy
Thoracic tumor
Thoracic tumor
Malignant pleura mesothelioma
Boron neutron capture therapy
Online AccessGet full text

Cover

More Information
Summary:Abstract Two patients, one with malignant pleural mesothelioma and one with a malignant short spindle cell tumor, received boron neutron capture therapy (BNCT). In each case, the tumors regressed or remained stable in size for 3–6 months following BNCT. No acute or late adverse events higher than grade 2 were observed.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0167-8140
1879-0887
DOI:10.1016/j.radonc.2008.06.009